指南与共识瓣膜病与结构性心脏病

慢性血流动力学显著主动脉瓣反流的结局与现行指南的局限性

Outcomes in Chronic Hemodynamically Significant Aortic Regurgitation and Limitations of Current Guidelines.
指南 / 共识 · J Am Coll Cardiol · 2019-03-04

该研究纳入2006至2017年748例≥中重度慢性主动脉瓣反流患者,48%接受主动脉瓣修复或置换。中位随访4.9年,17%死亡,左室收缩末期内径指数(LVESDi)是唯一与全因死亡独立相关的左室参数,理想截断值似乎低于既往推荐。

要点

  • LVESDi≥20 mm/m²与全因死亡风险增加相关,理想截断值可能低于现行推荐。
  • 主动脉瓣修复或置换与更好的生存相关。
  • Class II指征手术患者术后结局更好,值得更多关注。

核心结论

  • Class I指征(主要为症状)是主动脉瓣修复或置换的最常见触发因素。
  • LVESDi是唯一与全因死亡独立相关的左室参数,理想截断值似乎低于既往推荐。

研究设计与样本

  • 2006至2017年连续纳入≥中重度慢性主动脉瓣反流且无既往心脏手术、心肌梗死或明显冠心病的患者,共748例(58±17岁,82%男性)。

主要发现

  • 748例中387例(52%)接受药物治疗,361例(48%)接受主动脉瓣修复或置换。
  • 361例手术患者中334例(93%)符合指南标准:Class I指征284例(79%),其中症状236例;Class II指征50例(14%)。
  • 中位随访4.9年(四分位距2.3至8.3年),125例(17%)死亡。
  • 与LVESDi<20 mm/m²相比,LVESDi 20至25 mm/m²(HR 1.53;95%CI 1.01至2.31)和≥25 mm/m²(HR 2.23;95%CI 1.32至3.77)的死亡风险增加。
  • 主动脉瓣修复或置换与更好的生存相关(p<0.0001);Class I指征手术患者术后生存较差(p<0.003)。

关键数值与推荐

  • Class I指征284例(79%),其中症状236例;Class II指征50例(14%);无Class I或II指征而选择手术27例(7%)。

临床怎么用

  • LVESDi≥20 mm/m²提示死亡风险增加,应考虑更早干预。
  • Class II指征手术患者术后结局更好,应更加重视。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few data exist on the contemporary profiles and outcomes of patients with significant aortic regurgitation (AR). OBJECTIVES: This study sought to assess the benefits of aortic valve repair or replacement (AVR) and the prognostic value of left ventricular (LV) dimensions in significant AR. METHODS: From 2006 to 2017, consecutive patients with ≥moderate-severe chronic AR without prior heart surgery, myocardial infarction, or overt coronary artery disease were included. RESULTS: Of 748 participants (58 ± 17 years of age; 82% men), 387 (52%) were medically treated, and 361 (48%) had AVR. Of 361 patients having AVR, 334 (93%) met guideline criteria: Class I indications in 284 (79%) patients, which included symptoms in 236, and Class II indications in 50 (14%). The remaining 27 (7%) opted for surgery without Class I or II indications. At a median follow-up of 4.9 years (interquartile range: 2.3 to 8.3 years), 125 (17%) patients had died. Age, comorbidities, baseline symptoms, and higher LV end-systolic dimension index (LVESDi) were associated with all-cause mortality (all p ≤ 0.01). Compared with patients having LVESDi <20 mm/m2, those with LVESDi 20 to 25 mm/m2 (hazard ratio: 1.53; 95% confidence interval: 1.01 to 2.31) and ≥25 mm/m2 (HR: 2.23; 95% confidence interval: 1.32 to 3.77) had increased risks of death. AVR was associated with better survival (p < 0.0001). Patients with Class I indications for surgery had inferior post-operative survival (p < 0.003). CONCLUSIONS: Class I indications for surgery, mainly symptoms, are the most common triggers for AVR. Class II indications were associated with better post-operative outcome and thus merit more attention. LVESDi was the only LV parameter independently associated with all-cause mortality and the ideal cutoff seems to be lower than previously recommended.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Yang LT, Michelena HI, Scott CG, et al. Outcomes in Chronic Hemodynamically Significant Aortic Regurgitation and Limitations of Current Guidelines. J Am Coll Cardiol. 2019. PMID: 30846339. doi:10.1016/j.jacc.2019.01.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。